Activation of brain indoleamine 2,3-dioxygenase (IDO) by cytokines: a model of depressive disorders?

被引：3
|
作者：
Moreau, M [1 ]
Castanon, N [1 ]
Lestage, J [1 ]
机构：
[1] Inst Francois Magendie, LabNeurobiol Integrat, Bordeaux, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
10.1016/S0924-977X(05)80204-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] Synthesis of indoleamine 2,3-dioxygenase (IDO) inhibitor
    Suzuki, Takafumi
    Yokoyama, Yuuaku
    Tsutumi, Katsuhiko
    Yamaguchi, Tomoyuki
    Takikawa, Osamu
    Okuno, Hiroaki
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 62 (01) : 114 - 115
  • [2] The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
    von Bubnoff, D.
    Bieber, T.
    ALLERGY, 2012, 67 (06) : 718 - 725
  • [3] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [4] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [5] Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review
    Fellendorf, Frederike T.
    Bonkat, Nina
    Dalkner, Nina
    Schoenthaler, Elena M. D.
    Manchia, Mirko
    Fuchs, Dietmar
    Reininghaus, Eva Z.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (25) : 2107 - 2118
  • [6] Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model
    Wirthgen, Elisa
    Tuchscherer, Margret
    Otten, Winfried
    Domanska, Grazyna
    Wollenhaupt, Karin
    Tuchscherer, Armin
    Kanitz, Ellen
    INNATE IMMUNITY, 2014, 20 (01) : 30 - 39
  • [7] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [8] Development and characterization of an indoleamine 2,3-dioxygenase (IDO) deficient mouse model of preeclampsia
    Santillan, Mark
    Pelham, Christopher
    Ketsawatsomkron, Pimonrat
    Santillan, Donna
    Yang, Baoli
    Hunter, Stephen
    Sigmund, Curt
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S276 - S276
  • [9] Indoleamine 2,3-Dioxygenase (Ido) As A New Immunological Marker In Kidney
    Loiacono, Elisa
    Votta, Barbara
    Amore, Alessandro
    Peruzzi, Licia
    Puccinelli, Maria Paola
    Camilla, Roberta
    Vergano, Luca
    Guido, Giuliana
    Donadi, Maria Elena
    Coppo, Rosanna
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1525 - 1526
  • [10] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
12345